Karen Ackermann
Impact in
- Cell Biology top 10%
- Aldose Reductase and Taurine
- Cellular transport and secretion
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 3
- Chemical Synthesis and Analysis 3
- Oncology 6
- PARP inhibition in cancer therapy 2
- Co-authors
- William R. Sherman (9 shared papers)W. Richard Sherman (4 shared papers)Ana M. García (5 shared papers)Michael D. Lewis (5 shared papers)Michael P. Honchar (2 shared papers)M G Low (2 shared papers)Anthony H. Futerman (2 shared papers)Israel Silman (2 shared papers)
- Journals
- Diabetes (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Biochemical Journal (3 papers)Journal of Mass Spectrometry (2 papers)Metabolism (1 paper)
- Partner nations
- United StatesJapanIsrael
In The Last Decade
Karen Ackermann
26 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 86
- Cell Biology 201
- Pharmacology 145
- Molecular Biology 605
- Endocrinology, Diabetes and Metabolism 120
- Oncology 176
Countries citing papers authored by Karen Ackermann
This map shows the geographic impact of Karen Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Ackermann more than expected).
Fields of papers citing papers by Karen Ackermann
This network shows the impact of papers produced by Karen Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Ackermann. The network helps show where Karen Ackermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Karen Ackermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 202 | |
| 2 | 1985 | 137 | |
| 3 | 1987 | 113 | |
| 4 | 2010 | 88 | |
| 5 | 1986 | 75 | |
| 6 | 2015 | 71 | |
| 7 | 1985 | 62 | |
| 8 | 1987 | 54 | |
| 9 | 1989 | 54 | |
| 10 | 1985 | 53 | |
| 11 | 1985 | 49 | |
| 12 | 1986 | 30 | |
| 13 | 1985 | 27 | |
| 14 | 1986 | 22 | |
| 15 | 1987 | 19 | |
| 16 | 1986 | 19 | |
| 17 | 1998 | 17 | |
| 18 | 1982 | 14 | |
| 19 | 1994 | 13 | |
| 20 | 1995 | 11 |
About Karen Ackermann
Karen Ackermann is a scholar working on Molecular Biology, Oncology, Cell Biology, Plant Science and Pathology and Forensic Medicine, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Dermatologic Treatments and Research (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Chemical Synthesis and Analysis (3 papers), Hormonal and reproductive studies (2 papers), Bipolar Disorder and Treatment (2 papers), Phytase and its Applications (2 papers), Aldose Reductase and Taurine (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Cell Biology (201 citations), Pharmacology (145 citations), Molecular Biology (605 citations), Endocrinology, Diabetes and Metabolism (120 citations) and Oncology (176 citations). Karen Ackermann has collaborated with scholars based in United States, Japan and Israel. Frequent co-authors include William R. Sherman, W. Richard Sherman, Ana M. García, Michael D. Lewis, Michael P. Honchar, M G Low, Anthony H. Futerman, Israel Silman, Charles Kilo and Joseph R. Williamson. Their work appears in journals such as Diabetes, Bioorganic & Medicinal Chemistry Letters, Biochemical Journal, Journal of Mass Spectrometry and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.